How to explain the 'watch-and-wait' period to a CLL patient?
Current research at Weill Cornell and the New York Genome Center
How can we overcome ibrutinib resistance?
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
How is the landscape of Hodgkin lymphoma therapy changing?